Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.529, 2007-01, pp. : 12-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
NICE recommends Oncotype DX to guide breast cancer therapy . . .
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 672, 2013-01 ,pp. :
Access to resources
Recommend
Oncotype DX testing a winner for guiding breast cancer therapy
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 645, 2012-01 ,pp. :
Tamoxifen cost effective for primary breast cancer prevention
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 350, 2002-01 ,pp. :
Epoetin alfa cost effective in breast cancer with anaemia
Inpharma, Vol. 1, Iss. 1413, 2003-01 ,pp. :
Keeping abreast of Oncotype DX testing
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 651, 2012-01 ,pp. :